Case Presentation (00662100) : 51 Yr-Old Female With Multiple Comorbidities (HTN, Ibs, Gerd, and Recurrent Utis)

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 32

Case Presentation (00662100)

 51 yr-old female with multiple comorbidities (HTN, IBS, GERD, and recurrent UTIs)

 2 months Hx of dyspnea and chest discomfort

 Associated Symptoms: orthopnea, edema in LE, productive cough and abdominal pain.

 Underwent extensive work-up


Rule Out (On admission)
 Pneumonia

 Cardiac Heart Failure

 UTI
Work-up
 Chest X-ray: clear lungs, no pleural effusion. Normal cardiac silhouette.

 Bacterial Culture: Negative

 EKG: Normal

 Echocardiography: 18x22 mm mobile mass attached to the interatrial septum.


Results
Cardiac Tumors
BY JOHN Y N I COL A S ( M E D - I II ST U DENT)
CAR DI OVASCUL AR S URG ERY CLE R KS HIP
A M E R ICA N UN I V ERSITY OF BE I R U T, JA N UA RY 2 0 1 8
Outline
1. Introduction

2. Classification

3. Clinical Presentation

4. Diagnosis

5. Treatment
Introduction
 Cardiac Tumors Known since Middle Ages

 First successful resection in 1954 by Swedish surgeon Clarence Crafoord

 Diagnostic puzzle and therapeutic challenge


Classification

Benign

Primary

Malignant
Cardiac
Tumors

Secondary Metastatic
Classification: Primary Benign Tumors
Myxoma
 50 – 70% of all primary cardiac tumors

 Peak Age in 50s, women > men

 75% in L. Atrium, 18% in R. Atrium, and rarely in ventricles

 Mostly occurs in fossa ovalis; also in subendocardial tissue

or cardiac valves.

 Soft, gelatinous consistency. Soft surface covered with

thromboses.
Classification: Primary Benign Tumors
Myxoma
 90% are sporadic, with high recurrence rate.

 10% in Carney Syndrome (Autosomal Dominant):

o Cardiac and cutaneous myxomas

o Endocrine Hyperfunction, prolactinoma (case)

o Cutaneous Hyperpigmentation
Classification: Primary Benign Tumors
Endocardial Fibroelastosis
 Most Common Tumor affecting valves

 Average age  60 years-old

 Small, white, gelatinous mass

Lipoma
 Affects interatrial septum
Classification: Primary Benign Tumors
Rhabdomyoma
 Most common primary cardiac tumor in children

 Focal hamartomatous accumulation of striated cardiomyocytes

 Occurs in myocardium of the left ventricle or in the interventricular septum

 Associated with tuberous sclerosis, and congenital heart defects

 Regress spontaneously in 50% of patients.


Classification: Primary Malignant Tumors
 Sarcomas constitute 75% of all malignant cardiac tumors

 Mostly found in right atrium, but can occur in any chamber.

 Without treatment, life expectancy is only few months


Classification: Primary Malignant Tumors
Angiosarcoma
 Most Common, 30% of all malignant tumors
 Mostly in middle-aged men

Rhabdomyosarcoma
 Second most common
 Male = Female
 Found in any chamber (single or multiple) and may infiltrate cardiac valves
 Can spread and infiltrate pericardium, pleura and mediastinum
Classification: Primary Malignant Tumors
Fibrosarcoma
 Mainly in adults and may be multiple
 Arise in right atrium and display intracavitary growth, pericardium may be infiltrated.

Leiomyosarcoma
 All age groups, Male = Female
 Soft mass extending beyond the borders of the heart

Li-Fraumeni Syndrome
 Autosomal Dominant (mutation in TP53 gene on chromosome 17)
 In young patients, under age of 45.
Classification: Secondary Tumors
 Occur as result of peripheral tumors (mostly lung, breast, stomach, liver, colon, kidney)

 Spread by hematogenous or lymphogenous ways

 More frequent than primary tumors

 Unclear presentation, masked by the peripheral tumor

 Critical surgical management


Clinical Presentation
 General Symptoms
o Fever, fatigue, weight loss, nights weats, etc.

o Hemorrhagic pericardial effusion --> malignant tumors.

 Obstruction
o If close to valves --> mimics stenosis of mitral or tricuspid valves

o If infiltrating heart walls --> symptoms of hypertrophic or restrictive cardiomyopathy

o If expanding towards SVC --> SVC syndrome (facial swelling, head fullness, orthopnea, etc.)

o Mostly heart failure presentation


Clinical Presentation
 Arrhythmias
o If tumor infiltrating neural pathways or myocardium --> irregular heart beat, AV-block

o Mostly in fibromas

o Sudden Cardiac Death is sometimes the first presentation

 Embolisms
o Cardiac tumors are often first diagnosed after the patient has suffered a stroke

o Embolism of peripheral vasculature

o Pulmonary Artery Embolism


Diagnosis
 History
 Investigation Should begin with exclusion of a thrombus or a vegetation
 Echocardiography --> First diagnostic procedure
 If echo is non-confirmatory --> Try CT, MRI, or FDG-PET/CT (Benign Vs. Malignant)

Myxoma in Right Atrium Sarcoma in Right Nodular Recurrent


Atrium and Ventricle Sarcoma
Diagnosis
 In the absence of tumors elsewhere, a primary malignant cardiac tumor must be

assumed

 If Lymphoma suspected --> confirm by a tissue sample biopsy, followed by

chemotherapy and/or radiotherapy

 Coronary angiography helpful in determinig the extent of highly vascular tumors


Treatment
 Involves multidisciplinary team (oncologists, radiotherapists, and surgeons)

 No high level of evidence on the best treatment modality

 Surgical excision of the tumor is usually the treatment of choice

 Chemotherapy --> widespread or unresectable malignant disease

 Chemotherapy + Radiotherapy --> Primary Cardiac Lymphoma


Treatment: Simple Tumor Resection
 Mostly for Benign Tumors

 Care taken in connecting the heart–lung machine to avoid dislodging any tumor material

 Open both atria from the right superior pulmonary vein without injuring the tumor or its base

 Tumor and its root can then be removed from the septum

 Inspect all the chambers of the heart to exclude the presence of further tumors
Treatment: Complex Tumor Resection
 If tumor on right side is too advanced --> Resect right side

 Pulmonary blood flow assured by Fontan Circulation

 Chronic right heart failure may result


Treatment: Ex-situ Resection
 Heart can be removed from the thorax to facilitate complete
resection

 Done when tumor involves posterior wall of left atrium or dorsal


great vessels.

 Better exposure --> Complete resection and better long-term


outcome

 After resection, cardiac anatomy is restored with artificial


materials and heart is replanted
Treatment: Myxoma
 Classical approach --> surgical exploration through the left atrium

 Incision --> at the interatrial groove

 Inspection of the attachment to arterial wall or atrial septum

 Right atrium is then opened, if needed


Treatment: Fibroma
 Tumor resected from trans-tricuspidal and
transventricular approach

 Locate tumor on ventricular wall + enucleation


from wall

 Suture the endocardial layer to epicardium to


avoid intraparietal hematoma formation

 Gore-Tex patch necessary to close defect left


in anterior wall of right ventricle
Treatment: Endoscopic Robotic Resection
 Small incisions under the right armpit lateral to

the breast

 Biggest chest incision is the working port which is

15 mm in size

 Same level of effectiveness but is far less

invasive
Treatment: Endoscopic Robotic Resection

 Procedure does require cardiopulmonary bypass

 Peripheral catheter-based system

 Tumor is resected and removed using an “endobag”


Treatment: Endoscopic Robotic Resection

https://www.youtube.com/watch?time_continue=73&v=PK8o-udtqas
Treatment: Endoscopic Robotic Resection
Benefits of Endoscopic Robotic Resection:
o Less painful

o Faster Recovery

o Shorter hospital stay

o Sternum and chest bones intact --> less complications, less infections

o Minimal blood loss, less need for blood transfusions


Treatment: Endoscopic Robotic Resection
Risks of Endoscopic Robotic Resection:
o Need to convert to open techniques
o Aortic Dissection (tearing of the layers of aorta)
o Strokes
o Injury to the liver

Risks associated with bypass in robotic surgery:


o Injury to leg artery or vein
o Deep Vein Thrombosis
o Lymphocele (collection of fluid in groin area)
Thank you.

You might also like